You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letters
Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome
  1. Harun Çakmak,
  2. Tolga Kocatürk
  1. Department of Ophthalmology, Adnan Menderes University School of Medicine, Aydın, Turkey
  1. Correspondence to Dr Harun Çakmak, Department of Ophthalmology, Adnan Menderes University School of Medicine, Aydın 09100, Turkey; dharuncakmak{at}gmail.com

https://doi.org/10.1136/bjophthalmol-2014-305320

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read an interesting ‘Clinical science’ article by Dotan et al1 entitled ‘Intracameral recombinant tissue plasminogen activator (r-tPA) for refractory toxic anterior segment syndrome’. After studying the manuscript there are some issues that come to mind.

    First, their prospective study was performed between May 2010 and November 2011. r-tPA was injected into patients …

    View Full Text

    Footnotes

    • Contributors HÇ and TK wrote the letter.

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.